Abstract
The process of vision is initiated when the G protein-coupled receptor, rhodopsin (Rho), absorbs a photon and transitions to its activated Rho* form. Rho* binds the heterotrimeric G protein, transducin (Gt) inducing GDP to GTP exchange and Gt dissociation. Using nucleotide depletion and affinity chromatography, we trapped and purified the resulting nucleotide-free Rho*•Gt complex. Quantitative SDS-PAGE suggested a 2:1 molar ratio of Rho* to Gt in the complex and its mass determined by scanning transmission electron microscopy was 221±12 kDa. A 21.6Å structure then was calculated from projections of negatively stained Rho*•Gt complexes. The molecular envelope thus determined accommodated two Rho molecules together with one Gt heterotrimer, corroborating the heteropentameric structure of the Rho*•Gt complex.
Keywords: G protein-coupled receptor, heterotrimeric G protein, photoactivated rhodopsin, scanning transmission electron microscopy, transducin
Introduction
A wealth of structural, biophysical and biochemical data about its function makes rhodopsin (Rho) a paradigm for understanding G protein-coupled receptors (GPCRs) and their activation. GPCRs, essential proteins for signal transduction across cellular membranes, are involved in most physiological processes. Rho, the primary molecule in the rod visual signaling cascade, is activated by a single photon that isomerizes its bound inverse agonist, 11-cis-retinal, to its all-trans, full agonist state. This leads to formation of the Rho* activated state, which catalyzes nucleotide exchange on multiple transducin (Gt) heterotrimers, providing an initial signal amplification (Hofmann et al., 2009; Palczewski, 2006; Sakmar et al., 2002). The first crystal structure determined for a GPCR was that of Rho (Palczewski et al., 2000), and Rho crystals have yielded the highest resolution and only native structure of any GPCR determined to date (Okada et al., 2004). The structure of Rho* has been solved (Salom et al., 2006), the interaction site between Rho and the Gt C-terminus structurally defined (Choe et al., 2011; Scheerer et al., 2008; Standfuss et al., 2011), and the Gtα activation by Rho* characterized by site-directed spin labeling and spectroscopy (Van Eps et al., 2011). However, the most complete insight into the interactions between a GPCR and its cognate G protein is provided by the recent structure of the human β2 adrenergic receptor•Gs protein complex (Rasmussen et al., 2011). Despite this progress, the molecular mechanisms by which receptor-G protein activation occurs are still not fully understood (Han et al., 2009; Jastrzebska et al., 2011).
A long-standing question concerns the stoichiometry of the fully active receptor•G protein complex. Near-infrared light scattering experiments initially indicated a stoichiometry of 1:1 for an active Rho*•Gt complex (Kuhn et al., 1981), but subsequent studies on the light-dependent binding of Gt to Rho* suggested that two or even four receptors were needed for Gt coupling (Wessling-Resnick and Johnson, 1987). Extensive biophysical and biochemical evidence suggests the existence of GPCR dimers in living cells (Angers et al., 2002). Recent surface plasmon resonance measurements and a holistic systems modeling approach indicate that prevalently dimeric Rho and Gt form transient complexes (Dell'orco and Koch, 2011). These authors conclude that Rho molecules and Rho-Gt complexes can both absorb photons and trigger the visual cascade. Imaging of native rod outer segment (ROS) membranes by atomic force microscopy (AFM) revealed Rho to be organized in rows of parallel dimers (Fotiadis et al., 2003). Considering the native dimeric state of Rho, the surfaces of Rho and Gt, and the regions of both proteins postulated to be involved in complex formation, a Rho*-Rho dimer was proposed to be the functional unit required for Gt activation (Liang et al., 2003). Although activation of a single Rho suffices to trigger a physiological response (Bayburt et al., 2007; Baylor et al., 1979; Whorton, et al. 2008), these in vitro findings do not provide information about the actual stoichiometry of the Rho*•Gt complex in its native membrane.
The most compelling evidence for a dimer in GPCR-mediated signaling comes from in vivo studies of the luteinizing hormone receptor (LHR), which demonstrated intermolecular co-operation between ligand-binding deficient and G protein activation deficient mutants (Rivero-Muller et al., 2010). Functional complementation assays showed that the minimal signaling unit consists of two class A and a single G protein (Han et al., 2009), and dimerization of the β2-adrenergic receptor was found to be obligatory for cell surface targeting (Salahpour et al., 2004). Furthermore, studies probing the lateral diffusion of Rho in photoreceptor membranes (Govardovskii et al., 2009), as well as Monte Carlo simulations of Rho* and Gt in disc membranes support the binding of one Gt to at least two GPCRs and suggest that the high density packing of Rho into dimers and higher order oligomers provides a kinetic advantage that enables a rapid response to light (Dell'Orco and Schmidt, 2008).
To provide new information about the most native system available, we have purified the Rho*•Gt complex in the absence of GTP, and determined its stoichiometry by biochemical methods as well as its mass by scanning transmission electron microscopy (STEM). This complex has a mass of ~221 kDa, which is consistent with the biochemically measured stoichiometry of 2 Rho molecules (39 kDa) and one Gt heterotrimer (86 kDa) per complex, taking 1-2 detergent micelles into account. Model building demonstrates that the three-dimensional (3D) molecular envelope of negatively stained complexes accommodates one Rho dimer and one Gt heterotrimer, corroborating biochemical analyses and STEM mass measurements.
Results and Discussion
Purification and characterization of Rho*•Gt
Solubilized Rho was purified as described in Supplementary Information, bound to succinylated Concanavalin (sConA) affinity resin, photoactivated, and saturated with Gt. The reconstituted Rho*•Gt complex then was eluted with α-methyl-mannoside (Fig. 1A, middle panel). No complex formation was observed without illumination (Fig. 1A, upper panel) indicating that activated Rho was required for Gt binding. Moreover, the Rho*•Gt complex formed on the sConA affinity column was biochemically active, because Gt dissociated from Rho* when 200 μM GTPγS was applied to the column (Fig. 1A, bottom panel). Reverse phase HPLC confirmed that the purified complex was in the nucleotide-free state (Fig. S1A), and its UV-visible spectrum exhibited an absorbance maximum at 380 nm, characteristic of the Meta II activated state (Fig. S1B). Under acidic conditions the deprotonated Schiff base of the Meta II photoproduct became protonated, shifting its absorption peak to 440 nm (Fig. S1B), as would be expected for Meta II Rho. Retinoid analysis showed that the major isomerization state of chromophore in the complex was all-trans-retinal, with a minimal amount of dark state (11-cis-retinal) chromophore (Fig. S1C).
Fig. 1. Purification of the Rho*•Gt complex by sConA affinity chromatography and stoichiometry.
A) Formation of the complex between solubilized Rho coupled to sConA resin and Gt has been explored in the dark (top panel, diamond) or after illumination (middle panel). The functionality of Rho*•Gt complex is evidenced by its dissociation in the presence of 200 μM GTPγS (bottom panel). No complex formation was observed without photoactivation, indicating the necessity of activated Rho for Gt binding to occur. Rho*•Gt can be dissociated with GTPγS, indicating that Gt within the complex is functional. UB – unbound fraction; W – last wash; GTP – fractions eluted after incubation with GTPγS; 1-9 – fractions eluted with buffer containing α-methyl mannoside (see Material and Methods). 20 μl of each fraction were analyzed by Coomassie blue- and Sypro-Ruby-stained SDS-PAGE. Intensities of bands marked by * have been quantitatively assessed. # - marks fractions containing dissociated free Gt (bottom panel). ϫ - marks fractions containing residual Rho*•Gt complex and free Rho*. B) Sypro-Ruby stained SDS gel containing Rho*•Gt complexes from three independent purifications with the respective relative band intensities displayed in the bottom panel. Protein bands were quantified by Molecular Imager FX (BioRad). The calibration of relative band intensities is documented in Supplementary Information.
As previously noted, the type of detergent and quantity used to reconstitute the Rho*•Gt complex have a significant influence on complex stability (Jastrzebska et al., 2009a). Only alkyl maltosides, including n-tetradecyl-β-D-maltoside and n-dodecyl-β-D-maltoside (DDM), allowed purification of the isolated complex; non-maltoside detergents either dissociated the complex or inhibited its formation. sConA affinity chromatography allowed lipids to be removed without compromising reconstitution of the active complex on the column. Lipid removal was advantageous, as excess lipids characteristic for the sucrose density gradient purification protocol described previously increased sample heterogeneity (Jastrzebska et al., 2009b). Moreover, sConA affinity chromatography allowed the DDM concentration to be lowered to 0.5 mM, which sufficed to prevent Rho precipitation while maintaining the native Rho dimer conformation (Suda et al., 2004).
Stoichiometry and mass of the Rho*•Gt complex
Two different protein in-gel staining techniques allowed the ratio between Rho* and Gt in the purified Rho*•Gt complex to be measured (see Fig. S2 for the calibration procedure). Densitometric analysis of Sypro-Ruby stained SDS-gels from three independent purifications is displayed in Fig. 1B and yielded a ratio of 2:1 Rho*:Gt, consistent with the stoichiometry of sucrose gradient purified Rho*•Gt complexes reported previously (Jastrzebska et al., 2009b).
Unstained, freeze-dried Rho*•Gt complexes were imaged by low-dose dark-field STEM (Fig. 2A, and mass values calculated from their electron scattering power were assembled in a histogram (Fig. 2B). The major particle population had a mass of 221±12 kDa, whereas secondary peaks represented multiples of this value (Table 1). This result agrees best with a 2:1 Rho (39 kDa) : Gt (86 kDa) absolute stoichiometry because the expected heteropentamer mass is ~210-240 kDa, depending on the amount of bound detergent. To obtain particle dimensions, average projections were calculated for particles from the major population having a mass of ~220 kDa; class averages revealed elongated particles that are about 130 Å long and 90 Å wide (inset Fig. 2A).
Fig. 2. STEM mass determination.
A) Low-dose STEM dark-field image of freeze-dried non-crosslinked Rho*•Gt complex. White circles mark particles selected for mass analysis and grey circles the areas selected for background determination. Selection was based on size, shape and brightness of the particles. The large fraction of particles in this field with either low intensities or sizes smaller than 100 A resulted from dissociated Rho*•Gt complexes and are either smaller than 100 Å or have low intensities. Scale bar: 500 Å. Inset: A total of 136 particle projections from the major mass-histogram population (average mass 211 ± 17 kDa; B) were analyzed with EMAN software (Ludtke et al., 1999). In all, 116 particles were separated into the 3 classes shown. The class averages indicate that the projections of the selected unstained, freeze-dried particles are elongated and have a length of ~130 Å. The precision of the measurement is limited by the pixel size of 9.2 Å required to record digital, low-dose, dark-field STEM images for mass measurement. Scale bar: 150 Å. B) Histogram of particle masses measured for a freeze-dried, unstained Rho*•Gt sample by STEM. The major peak is at 221 kDa suggesting that the Rho*•Gt complex is composed of 2 Rho molecules (monomer mass: 39 kDa) and 1 Gt molecule (heterotrimer mass: 86 kDa) with associated DDM. The fitted Gaussian peaks have variable widths (standard deviations); the position of the major peak has an uncertainty of ±12 kDa (Table 1). Secondary peaks are Rho*•Gt aggregates comprising 2, 3 or 4 complexes.
Table 1. Overall experimental error of STEM mass analysis.
The mass calibration was performed by using tobacco mosaic virus (TMV) and the hexagonally packed intermediate (HPI) layer of Deinococcus radiodurans as standards. The calibration error is a conservative estimate accounting for all experimental errors related to sample preparation (background uncertainty), instrumentation, and mass-loss correction (Müller et al., 1992). SE is the standard error of the mean, and the overall uncertainty is estimated assuming statistical error propagation.
| Gauss peak position ± SD (kDa) | % of 790 particles under peak | Number of particles in Gauss peak | SE (kDa) | 5% calibration error (kDa) | Overall uncertainty (kDa) |
|---|---|---|---|---|---|
| 221 ± 84 | 61.3% | 484 | ± 3.8 | ± 11.1 | ± 12 |
| 429 ± 88 | 26.7% | 211 | ± 6.1 | ± 21.5 | ± 22 |
| 636 ± 95 | 7.7% | 61 | ± 12.2 | ± 31.8 | ± 34 |
| 975 ± 137 | 4.3% | 34 | ± 23.5 | ± 48.8 | ± 54 |
Size exclusion chromatography revealed two major peaks: a ~220 kDa peak, corresponding to the purified Rho*•Gt complex (peak #1), and an ~80 kDa peak (peak #2) corresponding to free Gt subunits (Fig. S3A). Purified DDM-solubilized Rho as well as the DDM-Gt complex eluted at ~140 kDa in control experiments (Fig. S3B). Size exclusion chromatography not only supports the 2:1 Rho:Gt stoichiometry but also demonstrates the fragility of this complex.
Visualization of Rho*•Gt complexes by TEM
Negatively stained preparations of crosslinked Rho*•Gt exhibited two major particle populations (Fig. 3). To obtain a statistically relevant estimate of these populations, the auto-boxing feature of EMAN2 was employed to select and visualize a large number of particles. The larger, elongated particles accounted for 32% of all particles on the grid with lengths of 130±6 Å (n=60) (Table 2) and variable widths. Such particles most likely represent the Rho*•Gt complex. The smaller particles had diameters of 82±6 Å (n=60), sizes characteristic of either Rho dimers solubilized in DDM (Suda et al., 2004) or heterotrimeric Gt (Jastrzebska et al., 2009a).
Fig. 3. TEM of negatively stained Rho*•Gt complexes.
A TEM image of negatively stained purified Rho*•Gt complexes is shown at the top. Regions marked by broken squares indicate elongated particles selected for structural analysis of the complex. Regions marked with broken circles indicate smaller particles, presumably Rho dimers or Gt. A set of 44 elongated particles is displayed at the bottom. Scale bar, 500 Å. Box dimensions, 250 Å × 250 Å. TMV was used as a standard for particle size calibration.
Table 2. Data collection and statistical analysis of particle size distribution.
Images have been collected with a Tf20 and a CM10 transmission electron microscope. Particles were either selected using the auto-boxing feature of EMAN2 (Tang et al., 2007) for particle size statistics and manually for 3D reconstruction.
|
Raw data collection
| |||||||||
| Rho*•Gt purification method | sConA affinity chromatography with cross-linking | sConA affinity chromatography with cross-linking and sizing chromatography | sConA affinity chromatography without cross-linking | ||||||
| # of preparations | 4 | 1 | 1 | ||||||
| # of images collected per preparationa | 50-100 at 0° | 100 at 0° | 26 at 0° | ||||||
| 50-100 at 45° | 200 at 45° | 24 at 45° | |||||||
| 20-30 at 60° | 20 at 60° | ||||||||
|
Particles selected by auto-boxing for size statistics | |||||||||
| Total # of particles | 5627 | 9782 | 5069 | ||||||
| Type of particlesb | small | elongated | aggregated | small | elongated | aggregated | small | elongated | aggregated |
| (% of total) | 66 | 32 | 2 | 26 | 72 | 2 | 75 | 25 | <1 |
| Particle size (A)c | 82±6 | 130±6 | 152±8 | 82±6 | 133±8 | 177±13 | 81±7 | 131±6 | 165±18 |
|
Particles selected manually for 3D reconstruction | |||||||||
| Total number of elongated particlesd | 5156 | 5663 | 1133 | ||||||
The number of images collected for each preparation varied between values given.
Auto-boxed particles were selected by eye based on their size to determine the size distribution.
60 small or elongated particles and 30 aggregates were measured
Particles were selected by eye using BOXER.
Because gel filtration chromatography (Fig. S3A) suggested that the complex dissociates during purification, crosslinked samples were separated by size exclusion chromatography just prior to grid preparation. Again, two size populations were observed, but in this case the elongated particles were the major species (72%, Table 2).
Negatively stained preparations of uncrosslinked Rho*•Gt revealed the same elongated complexes (length=131±6 Å; Table 2) found predominately in the crosslinked preparation after size exclusion chromatography. The percentage of larger particles was similar to that calculated for crosslinked Rho*•Gt preparations before sizing chromatography (25%; Table 2). These results suggest that neither adsorption to the carbon film nor staining with uranyl acetate markedly promoted complex dissociation, but that cross-linking is required to augment the fraction of intact Rho*•Gt complexes.
3D structure of the Rho*•Gt complex
Structural variability and possible dissociation of the Rho*•Gt complex not only constituted a challenge for particle selection but also required a large particle pool to obtain class averages suitable for calculating an unbiased initial model. We therefore established an initial 3D map from projections of crosslinked Rho*•Gt complexes enriched by sizing chromatography. Because these elongated complexes adsorbed to the carbon film in preferential orientations, images were recorded at 0°, 45° and 60° tilt to improve the coverage of projection angles. Elongated particles were selected manually for 3D reconstruction of the negatively stained complex, namely 5,156 projections recorded with a Philips CM10 and 5,663 with an FEI TF20. CTF-corrected projections of samples prepared by the sandwich method (Cheng et al., 2006) were used to initiate calculation of the 3D map. In all, 160 class averages were calculated to sample the projection angle range at sufficient density (Figs. 4A and S4C). The highest scoring initial model determined by EMAN2 (Tang et al., 2007) was then refined against the TF20 data (5,663 projections), the CM10 data (5,156 projections) and the total data set (10,819 projections). Refinement results were similar for all data sets, and converged within the first few refinement cycles (Fig. S4A). Fig. 4B (top row) shows different views of the 3D map contoured to comprise a mass of 220 kDa. According to the EMAN2 even-odd test, the resolution of the 3D map obtained from the final refinement run that employed 10,819 projections was 21.6 Å (Fig. S4B) with extensive angular coverage (Fig. S4C).
Fig. 4. 3D map of the Rho*•Gt complex at 21.6 Å resolution.
A) Class averages of the Rho*•Gt complex obtained by manual selection of particles prepared by the sandwich negative staining method. This set was used to calculate an initial model. Asterisks mark class averages, which document the bipartite morphology of the complex. (Box dimensions, 250 Å × 250 Å. B) Top row: The 3D map calculated from projections of crosslinked Rho*•Gt complexes has a resolution of 21.6 Å according to the FSC function, 50% criterion (see Fig. S4B). The views were generated by Chimera (Pettersen et al., 2004), rotating the Rho*•Gt complex around its long axis in 45° increments. Bottom row: Independent 3D map having a resolution of 28.4 Å calculated from projections of native Rho*•Gt complexes. Scale bar, 100 Å. C) Semi-empirical model of the Rho*•Gt complex fitted into a 3D envelope established by single particle analysis. Because a single photon can activate the complex, the Rho molecule, which directly interacts with the Gt C-terminus is depicted in yellow to denote that it is the activated subunit. The second Rho is denoted in red. Gtα, Gtβ, Gtγ are colored dark blue, green and magenta, respectively.
As a control, a data set of negatively stained uncrosslinked Rho*•Gt complexes comprising 634 projections from images recorded at 0° and 499 particles recorded at 45° tilt was used to calculate 31 class averages (Fig. S5A). The initial model obtained was then refined against this data set, yielding the 3D map displayed in Fig. 4B, lower row. This map exhibits a resolution of 28.4 Å (Fig. S5B) and is markedly similar to the 3D map obtained from crosslinked preparations.
Our results contrast the recent structure of the human β2 adrenergic receptor•Gs protein complex (Rasmussen et al., 2011), which reveals a single GPCR molecule interacting with the Gs heterotrimer. Nevertheless, the consistency of biochemical analyses and our STEM mass determination (Figs. 1 and 2) together with the two independent 3D maps obtained (Fig. 4B) provide solid evidence for the heteropentameric nature of the Rho*•Gt complex.
Modeling of Rho dimer and Gt into the molecular envelope
The calculated 3D map shows the Rho*•Gt complex to be ~ 130 Å long and 30 Å thick, with a narrower 70 Å wide end, and a wider end with two distinct domains (Fig. 4B). To explore possible arrangements of the components, available structures of Rho and Gt were fitted into the map by hand (supplementary information). One of the two domains of the wider end corresponded best to the Gβγ subunits, indicating the orientation of the intact transducin heterotrimer (PDB ID: 1GOT; (Lambright et al., 1996)). The narrower end was much too large to contain only one Rho monomer, and could accommodate a Rho dimer. Further information was obtained by analyzing both X-ray structures of GPCRs that contain crystallographic or non-crystallographic dimers and computed models of Rho packing in ROS discs. All these dimers were explored for the best fit, both geometrically and biochemically. Squid rhodopsin, CXCR4 and the 1N3M model are quite similar and all fit well into the map obtained by EM. Because the extreme C terminus of Gtα is not observed in the 1GOT structure, we spliced a corresponding α-helical segment into this region based on the structures of the Rho*•Gtα-peptide complex (PDB ID: 2X72, 3DQB).
The molecular envelope of the Rho*•Gt complex accommodates one Rho dimer and one nucleotide-bound Gt heterotrimer (Figs. 4C and 5). According to this model, the C terminal helix of Gtα is close to the position observed in the opsin + Gt peptide structures (Choe et al., 2011; Standfuss et al., 2011). Furthermore, the extreme N-terminus (not observed in the 1GOT structure) would also be in close proximity to helix 8 on the receptor, best satisfying receptor - N-terminal interactions upon activation (Downs et al., 2006; Kisselev and Downs, 2006). In this orientation the Gγ and the Gα subunits could insert their respective farnesylation and myristoylation moieties into the plasma membrane (Fig. 5).
Fig. 5. Proposed orientation of the Rho*-Gt complex in the plasma membrane and comparison with the T4L-β2AR-Gs-nb structure.
Activation of rhodopsin by a single photon of light results in a Rho*-Rho heterodimer; the Rho* within the dimer binds to Gt through an induced fit mechanism, allowing the C-terminus of Gtα and other contact points in Gt to interact productively to initiate expulsion of GDP from the subunit. Once Gt attains the nucleotide-free state, a GTP becomes bound from the bulk solution, which promotes dissociation of Gt from Rho and Gt into its component Gtα and Gtβγ subunits thereby triggering downstream signaling events. A) Model with the 1GOT (GDP bound alpha) structure leaves a large portion of unoccupied density above the second rhodopsin molecule. B) A 30° hinge-like motion of the alpha helical domain allows this domain to fill the unoccupied density noted with the “un-bent” structure. EPR experiments (Van Eps et al., 2011) and the T4L-β2AR-Gs-nb structure (Rasmussen et al., 2011) indicate that this change in structure is feasible. C) Fitting the T4L-β2AR-Gs-nb into our EM density reveals that the conformation of the Gα helical domain is inconsistent with our observed density. Given the 130 ° rotation observed in that structure, it is likely that in the nucleotide free state the Gα helical domain is free to “flop” about. The Rho* molecule (or β2-adrenergic receptor in the case of the T4L-β2AR-Gs-nb structure), which directly interacts with the Gt C-terminus is depicted in yellow to denote that it is the activated subunit. The second Rho is colored red. Gα, Gβ, Gγ are colored dark blue, green and magenta, respectively.
Given the recent results that demonstrate a marked flexibility of the Gα subunit in the nucleotide empty state (Rasmussen et al., 2011; Van Eps et al., 2011), we treated the alpha helical and ras-like domains as independent rigid bodies connected by residues 50-58 and 172-178 forming a flexible hinge. By opening the alpha subunit at the nucleotide binding cleft by about 30°, the fit markedly improved (Figs. 4C and 5B) compared to that obtained with the nucleotide bound form of Gtα (Fig. 5A). This rotation is much smaller in magnitude than the 130° opening of the alpha subunit seen in the β2 adrenergic receptor•Gs protein T4L-β2AR-Gs-nb) structure (PDB ID: 3SN6) (Rasmussen et al., 2011) and is in line with the magnitude of changes observed in recent EPR studies (Van Eps, 2011 #35).
When we superpose the T4L-β2AR-Gs-nb structure with our model, it reveals a very similar interaction between the C-terminal helix and the cleft formed by the outward movement of Helix 5 and 6 upon activation. The T4L-β2AR-Gs-nb fits quite well into our density with the exception of the extremely open conformation of the alpha-helical domain; however, there is a significant unoccupied density, which corresponds to the position for the second Rho comprising the dimer observed within our preparations (Fig. 5C).
In short, this work presents the first direct observation of the native, physiologically active complex formed between Rho and Gt and indicates that the minimal functional signaling unit is a dimer of Rho complexed to a single Gt heterotrimer. This is firmly supported by biochemical analyses and STEM mass measurements. In addition, X-ray structures determined of the individual components were used together with extant biochemical data about interactions present in the complex to interpret the molecular envelope obtained by single particle 3D reconstruction methodology. The low-resolution structure of the heteropentameric Rho*•Gt complex is compatible with a wealth of results from biochemical, biophysical and in-vivo analyses, and provides a working model of the native Rho*•Gt complex as well as GPCR-G protein signaling in general.
Methods
Purification of Rho*•Gt complex by sConA A affinity chromatography
sConA affinity resin was prepared by coupling sConA (Vector Laboratories, CA) to CNBr-activated agarose (Santa Cruz Biotechnology Inc., Santa Cruz, CA) at a density of 8 mg sConA/ml of resin. A column containing sConA resin was equilibrated with 20 mM BTP, pH 6.9 containing 120 mM NaCl, 1 mM MnCl2, 1 mM CaCl2, 1 mM MgCl2, 1 mM DTT and 0.5 mM DDM (buffer A). Purified Rho was diluted to ~ 0.2 mg/ml and loaded onto the column at 0.5 ml/min. The resin was washed with 5 column volumes of buffer A and then illuminated for 10 min with a 150 Watt fiber light (Dolan Jenner Industries Inc.) delivered through a 480-520 nm band pass filter. Purified native-expressed Gt, diluted to ~ 0.2 mg/ml with buffer A, was applied to the column immediately after light exposure at 0.5 ml/min and washed with 10 column volumes of buffer A. Complex was eluted at 0.2 ml/min with buffer A containing 200 mM α-methyl-D-mannoside. Protein elution profile was examined by SDS-PAGE and fractions containing Rho*•Gt complex were used for TEM and STEM analysis. Protein concentration was determined by Bradford ULTRA (Novexin, UK) using bovine serum albumin as a standard.
STEM measurements of the Rho*•Gt complex
Purified complex was diluted 30x in buffer A and immediately adsorbed for 1 min to glow-discharged, thin carbon films spanning a thick fenestrated carbon film supported by a gold-coated 200 mesh copper grid. Grids were washed on 8 droplets of quartz double-distilled water, blotting after each drop, quick frozen in liquid nitrogen and freeze-dried at -80°C and 5·10-8 Torr overnight in a Vacuum Generator HB-5 STEM interfaced to a modular computer system (Tietz Video and Image Processing Systems). Dark-field images comprising 512×512 pixels of 9.2 Å diameter were recorded at an acceleration voltage of 80 kV, depositing recording doses of 5 ± 0.3 electrons/Å2. Beam-induced mass-loss was experimentally determined and corrected for as described (Müller et al., 1992). Tobacco Mosaic Virus (TMV; kindly supplied by R. Diaz-Avalos) and the hexagonally packed intermediate layer of Deinococcus radiodurans (HPI-layer; kindly supplied by H. Engelhardt) served for absolute mass calibration.
Mass analysis was carried out with the MASDET program package (Krzyzanek et al., 2009). Particles having a size between ~100-200 Å were selected in optimized circular boxes, total mass was calculated and background subtracted. Final mass values were binned into histograms and fitted by a series of Gaussian curves. The overall experimental uncertainty of the results (±12 kDa for the main population) was estimated from the corresponding SE (SE = SD/√n) and the ~5% uncertainty in the calibration of the instrument by calculating the square root of the sum of the squares (Table 1).
TEM of negatively stained Rho*•Gt complex and image analysis
Purified Rho*•Gt complex was prepared with or without cross-linking with 5% glutaraldehyde for 15 min on ice. The cross-linking reaction was quenched with 100 mM Tris-HCl pH 8.0 for 10 min. Samples were diluted to ~20 μg/ml in buffer A and adsorbed for 1 min to glow-discharged, 400 mesh, carbon-coated grids. Grids were washed on 6-8 drops of distilled H2O and negatively stained with 2% (w/v) uranyl acetate. Both single film and double film sandwich negative staining methods were used (Cheng et al., 2006). Micrographs were either taken with a Philips CM 10 (Philips Research, Hamburg, Germany) operated at 80 kV or an FEI TF20 operated at 200 kV (FEI, Eindhoven, Netherlands). Electron micrographs were recorded at 0°, 45° or 60° tilt, either at a nominal magnification of 136,000 × on a Veleta – 2k × 2k side-mounted TEM CCD Camera (Olympus) (CM10) or 69,000 × on a Gatan Ultrascan 4k CCD (Gatan Inc, Pleasanton, CA 94588, USA) (TF20). Images were scaled according to the magnification determined by measuring the meridional reflection of co-prepared TMV.
Image processing was performed with the EMAN and EMAN2 software packages (Ludtke et al., 1999; Tang et al., 2007). Particles were selected manually by using BOXER or automatically using the auto-boxing feature of EMAN2. The latter method was used only for picking all recognizable particles to determine the particle size distribution. For CTF correction, a Wiener filter approach was implemented in the SEMPER package (Saxton, 1996), and applied to all images prior to particle selection. For images of tilted samples the defocus was determined for 8x8 regions containing 5122 pixel to define tilt angle and axis. Stripes with a defocus range Δf < 50nm were selected, CTF-corrected and merged in the CTF-corrected image. 160 class averages were calculated from the Rho*•Gt complexes prepared by the sandwich method and recorded with TF20 at a 0°, 45° and 60° tilt (5,663 projections). The EMAN2 module e2initialmodel.py calculated initial models from this class average set, and the best initial model was refined against the TF20, the CM10, and the combined data sets.
Modeling procedure
Available structures of Rho and Gt were fitted into the map by hand. The crystal structures containing dimers analyzed included photoactivated rhodopsin PDB ID: 2I37, opsin PDB ID: 3CAP, squid rhodopsin PDB ID: 2Z73 and CXCR4 PDB ID: 3ODU, and a model of Rho derived from AFM constraints PDB ID: 1N3M. All of the putative dimers were explored for the best fit both geometrically and biochemically.
Supplementary Material
Acknowledgments
This research was supported in part by grants EY008061, EY019718, GM079191 and P30EY11373 from the National Institutes of Health, Foundation Fighting Blindness, an unrestricted grant from Amgen Inc., and the Swiss National Foundation grant 3100A0–108299 to AE. KP is John H. Hord Professor of Pharmacology.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Supplementary information is available at J. Structural Biology online
REFERENCES
- Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol. 2002;42:409–35. doi: 10.1146/annurev.pharmtox.42.091701.082314. [DOI] [PubMed] [Google Scholar]
- Bayburt TH, Leitz AJ, Xie G, Oprian DD, Sligar SG. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J Biol Chem. 2007;282:14875–81. doi: 10.1074/jbc.M701433200. [DOI] [PubMed] [Google Scholar]
- Baylor DA, Lamb TD, Yau KW. Responses of retinal rods to single photons. J Physiol. 1979;288:613–34. [PMC free article] [PubMed] [Google Scholar]
- Cheng Y, Wolf E, Larvie M, Zak O, Aisen P, et al. Single particle reconstructions of the transferrin-transferrin receptor complex obtained with different specimen preparation techniques. J Mol Biol. 2006;355:1048–65. doi: 10.1016/j.jmb.2005.11.021. [DOI] [PubMed] [Google Scholar]
- Choe HW, Kim YJ, Park JH, Morizumi T, Pai EF, et al. Crystal structure of metarhodopsin II. Nature. 2011;471:651–5. doi: 10.1038/nature09789. [DOI] [PubMed] [Google Scholar]
- Dell'Orco D, Schmidt H. Mesoscopic Monte Carlo simulations of stochastic encounters between photoactivated rhodopsin and transducin in disc membranes. J Phys Chem B. 2008;112:4419–26. doi: 10.1021/jp709963f. [DOI] [PubMed] [Google Scholar]
- Dell'orco D, Koch KW. A dynamic scaffolding mechanism for rhodopsin and transducin interaction in vertebrate vision. Biochem J. 2011 doi: 10.1042/BJ20110871. [DOI] [PubMed] [Google Scholar]
- Downs MA, Arimoto R, Marshall GR, Kisselev OG. G-protein alpha and beta-gamma subunits interact with conformationally distinct signaling states of rhodopsin. Vision Res. 2006;46:4442–8. doi: 10.1016/j.visres.2006.07.021. [DOI] [PubMed] [Google Scholar]
- Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, et al. Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature. 2003;421:127–8. doi: 10.1038/421127a. [DOI] [PubMed] [Google Scholar]
- Govardovskii VI, Korenyak DA, Shukolyukov SA, Zueva LV. Lateral diffusion of rhodopsin in photoreceptor membrane: a reappraisal. Mol Vis. 2009;15:1717–29. [PMC free article] [PubMed] [Google Scholar]
- Han Y, Moreira IS, Urizar E, Weinstein H, Javitch JA. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol. 2009;5:688–95. doi: 10.1038/nchembio.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hofmann KP, Scheerer P, Hildebrand PW, Choe HW, Park JH, et al. A G protein-coupled receptor at work: the rhodopsin model. Trends Biochem Sci. 2009;34:540–52. doi: 10.1016/j.tibs.2009.07.005. [DOI] [PubMed] [Google Scholar]
- Jastrzebska B, Goc A, Golczak M, Palczewski K. Phospholipids are needed for the proper formation, stability, and function of the photoactivated rhodopsin-transducin complex. Biochemistry. 2009a;48:5159–70. doi: 10.1021/bi900284x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jastrzebska B, Debinski A, Filipek S, Palczewski K. Role of membrane integrity on G protein-coupled receptors: Rhodopsin stability and function. Prog Lipid Res. 2011;50:267–77. doi: 10.1016/j.plipres.2011.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jastrzebska B, Golczak M, Fotiadis D, Engel A, Palczewski K. Isolation and functional characterization of a stable complex between photoactivated rhodopsin and the G protein, transducin. FASEB J. 2009b;23:371–81. doi: 10.1096/fj.07-114835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kisselev OG, Downs MA. Rhodopsin-interacting surface of the transducin gamma subunit. Biochemistry. 2006;45:9386–92. doi: 10.1021/bi060806x. [DOI] [PubMed] [Google Scholar]
- Krzyzanek V, Muller SA, Engel A, Reichelt R. MASDET-A fast and user-friendly multiplatform software for mass determination by dark-field electron microscopy. J Struct Biol. 2009;165:78–87. doi: 10.1016/j.jsb.2008.10.006. [DOI] [PubMed] [Google Scholar]
- Kuhn H, Bennett N, Michel-Villaz M, Chabre M. Interactions between photoexcited rhodopsin and GTP-binding protein: kinetic and stoichiometric analyses from light-scattering changes. Proc Natl Acad Sci U S A. 1981;78:6873–7. doi: 10.1073/pnas.78.11.6873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lambright DG, Sondek J, Bohm A, Skiba NP, Hamm HE, et al. The 2.0 A crystal structure of a heterotrimeric G protein. Nature. 1996;379:311–9. doi: 10.1038/379311a0. [DOI] [PubMed] [Google Scholar]
- Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, et al. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem. 2003;278:21655–62. doi: 10.1074/jbc.M302536200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ludtke SJ, Baldwin PR, Chiu W. EMAN: semiautomated software for high-resolution single-particle reconstructions. J Struct Biol. 1999;128:82–97. doi: 10.1006/jsbi.1999.4174. [DOI] [PubMed] [Google Scholar]
- Müller SA, Goldie KN, Bürki R, Häring R, Engel A. Factors Influencing the Precision of Quantitative Scanning Transmission Electron Microscopy. Ultramicroscopy. 1992;46:317–334. [Google Scholar]
- Okada T, Sugihara M, Bondar AN, Elstner M, Entel P, et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol. 2004;342:571–83. doi: 10.1016/j.jmb.2004.07.044. [DOI] [PubMed] [Google Scholar]
- Palczewski K. G protein-coupled receptor rhodopsin. Annu Rev Biochem. 2006;75:743–67. doi: 10.1146/annurev.biochem.75.103004.142743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 2000;289:739–745. doi: 10.1126/science.289.5480.739. [DOI] [PubMed] [Google Scholar]
- Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605–12. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
- Rasmussen SG, Devree BT, Zou Y, Kruse AC, Chung KY, et al. Crystal structure of the beta(2) adrenergic receptor-Gs protein complex. Nature. 2011 doi: 10.1038/nature10361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rivero-Muller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, et al. Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci U S A. 2010;107:2319–24. doi: 10.1073/pnas.0906695106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sakmar TP, Menon ST, Marin EP, Awad ES. Rhodopsin: insights from recent structural studies. Annu Rev Biophys Biomol Struct. 2002;31:443–84. doi: 10.1146/annurev.biophys.31.082901.134348. [DOI] [PubMed] [Google Scholar]
- Salahpour A, Angers S, Mercier JF, Lagace M, Marullo S, et al. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem. 2004;279:33390–7. doi: 10.1074/jbc.M403363200. [DOI] [PubMed] [Google Scholar]
- Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc Natl Acad Sci U S A. 2006;103:16123–8. doi: 10.1073/pnas.0608022103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saxton WO. Semper: Distortion Compensation, Selective Averaging, 3-D Reconstruction, and Transfer Function Correction in a Highly Programmable System. J Struct Biol. 1996;116:230–6. doi: 10.1006/jsbi.1996.0035. [DOI] [PubMed] [Google Scholar]
- Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature. 2008;455:497–502. doi: 10.1038/nature07330. [DOI] [PubMed] [Google Scholar]
- Standfuss J, Edwards PC, D'Antona A, Fransen M, Xie G, et al. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature. 2011;471:656–60. doi: 10.1038/nature09795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Suda K, Filipek S, Palczewski K, Engel A, Fotiadis D. The supramolecular structure of the GPCR rhodopsin in solution and native disc membranes. Mol Membr Biol. 2004;21:435–46. doi: 10.1080/09687860400020291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, et al. EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol. 2007;157:38–46. doi: 10.1016/j.jsb.2006.05.009. [DOI] [PubMed] [Google Scholar]
- Van Eps N, Preininger AM, Alexander N, Kaya AI, Meier S, et al. Interaction of a G protein with an activated receptor opens the interdomain interface in the alpha subunit. Proc Natl Acad Sci U S A. 2011;108:9420–4. doi: 10.1073/pnas.1105810108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wessling-Resnick M, Johnson GL. Transducin interactions with rhodopsin. Evidence for positive cooperative behavior. J Biol Chem. 1987;262:12444–7. [PubMed] [Google Scholar]
- Whorton MR, Jastrzebska B, Park PS, Fotiadis D, Engel A, et al. Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J Biol Chem. 2008;283:4387–94. doi: 10.1074/jbc.M703346200. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





